S&P Futures
5,888.75 -3.75 (-0.06%) Dow Futures
43,050.00 -119.00 (-0.28%) Nasdaq Futures
20,526.00 -16.00 (-0.08%) Russell 2000 Futures
2,244.60 -1.60 (-0.07%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,763.60 +3.80 (+0.14%)
Themis Medicare Limited (THEMISMED.NS)
Themis Medicare Limited
11/12 Udyog Nagar Industrial Estate
S. V. Road Goregaon (West)
Mumbai 400104
India
91 22 6760 7080
https://www.themismedicare.com
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 1,509
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Dinesh Shantilal Patel CChem., FRSC(Lond.), Ph.D. | Executive Chairman | 26.21M | N/A | 1948 |
| Dr. Sachin Dinesh Patel CChem., Ph.D. | CEO, MD & Executive Director | 26.21M | N/A | 1975 |
| Ms. Reena Sachin Patel | VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | N/A | N/A | N/A |
| Mr. Tushar J. Dalal A.C.A. | Chief Financial Officer | 2.27M | N/A | N/A |
| Mr. Sangameshwar Ramnarayan Iyer A.C.S., L.L.B. | Compliance Officer & Company Secretary | 1.29M | N/A | N/A |
Description
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Corporate Governance
Themis Medicare Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
